WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 252
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 302

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 10  10  10  10  10 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported case

(Click for retrospective incidence data for Tuvalu)
Diphtheria
Japanese encephalitis
Measles 509 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tuvalu)
Vaccine year result method % card seen                                                
BCG 2006  84  DHS   33  99*  99*  99*  99*  99* 
DTP1 2006  78  DHS   33  99*  99*  99*  99*  80 
DTP3 2006  62  DHS   33  90  97  96  89  82 
DTP4         
IPV1         
HepB_BD          97  99*  98  99  99* 
HepB3          90  97  96  89  81 
Hib3          90  97  96  89 
JapEnc         
MCV1          96  98  98  85  81 
MCV2          84  93  90  70 
PCV1         
PCV3         
Pol3 2006  60  DHS   33  90  97  96  89  82 
Rota1         
Rota_last         
Rubella1          96  98  98  85 
TT2plus 2006  24  DHS   33  99*  99*  99*  99*  65 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tuvalu)
BCG 99  99  99  99  99  99  96  99 
DTP1 99  99  99  99  99  93  99  61 
DTP3 90  90  97  96  89  82  99  36 
HepB3 90  90  97  96  89  81 
HepB_BD 97  97  99  98  99  99 
Hib3 90  90  97  96  89 
MCV1 96  96  98  98  85  81  95 
MCV2 84  84  93  90  87 
PCV3
Pol3 90  90  97  96  89  82  84  23 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 38
From 80 to 89% 75
From 50 to 79% 13
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 5-6 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
MR 12, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
TT 1st contact; +4 weeks; +5 years Yes pregnant mothers/trauma cases

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   Yes  Yes  Yes  No  No  No 
What years does the MYP cover? number     2011-2012         
Nº of districts with microplans that include activities to raise immunization coverage number      

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%   113  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100%   88  100  38  13    100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND     Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR     Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%      

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.